pharmaceutical companies

Death by Intellectual Property

Via Suburban Guerilla, there's a link to the Dembot blog, where Andrew Baron posts an open letter to James C. Mullen, the chairman of Biogen, Inc. (the first link is just an excerpt of the second, which includes more detail).

Baron's father has multiple myeloma and is near death. Biogen Idec produces a drug called Tysabri (natalizumab) which might save Andrew's father's life.